FDA Approves Keytruda for Early-Stage Triple-Negative Breast Cancer July 27, 2021 The U.S. Food and Drug Administration (FDA) has approved Keytruda plus chemotherapy before surgery, followed by Keytruda alone after surgery to treat early-stage triple-negative breast cancer with a high risk of recurrence. Read more...
Keytruda Before and After Surgery Improves Outcomes in Early-Stage Triple-Negative Breast Cancer July 27, 2021 The immunotherapy medicine Keytruda plus chemotherapy before surgery and Keytruda alone after surgery improved event-free survival better than chemotherapy alone in women diagnosed with early-stage triple-negative…
Hello everyone, So I had a stereotactic core biopsy of the left on 7/1/2021. Results: Benign breast tissue showing fibrocystic change and focal fibroadenomatous changes. On the same day, 7/1/21, I had sonogram guided core biopsies of two locations on the right. Well, both locations on the right side are Invasive ductal…
MO just informed me yesterday that the lymph node biopsy showed positive for the breast cancer. Stated that the treatment would be different than previously planned. No surgery or radiation and Abroxane (chemo). Said that I would be in chemo for the rest of my life. I was too shocked to ask questions. Anyone been through…